Porto Alegre, RIO%20GRANDE%20DO%20SUL1 Active Studies

Ulcerative Colitis Clinical Trials in Porto Alegre, RIO%20GRANDE%20DO%20SUL

Find 1 actively recruiting ulcerative colitis clinical trials in Porto Alegre, RIO%20GRANDE%20DO%20SUL. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
15
Enrolling

Recruiting Ulcerative Colitis Studies in Porto Alegre

About Ulcerative Colitis Clinical Trials in Porto Alegre

Ulcerative colitis is a chronic inflammatory bowel disease that causes inflammation and ulcers in the innermost lining of the colon and rectum. It typically presents with bloody diarrhea, abdominal pain, and urgency. Treatment includes aminosalicylates, corticosteroids, immunosuppressants, and biologics.

There are currently 1 ulcerative colitis clinical trials recruiting participants in Porto Alegre, RIO%20GRANDE%20DO%20SUL. These studies are seeking a combined 15 participants. Research is being sponsored by Prevail Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ulcerative Colitis Clinical Trials in Porto Alegre — FAQ

Are there ulcerative colitis clinical trials in Porto Alegre?

Yes, there are 1 ulcerative colitis clinical trials currently recruiting in Porto Alegre, RIO%20GRANDE%20DO%20SUL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Porto Alegre?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Porto Alegre research site will contact you about next steps.

Are clinical trials in Porto Alegre free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Porto Alegre studies also compensate for your time and travel.

What ulcerative colitis treatments are being tested?

The 1 active trials in Porto Alegre are testing new therapies including novel drugs, biologics, and treatment approaches for ulcerative colitis.

Data updated March 2, 2026 from ClinicalTrials.gov